Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023.
Lee JA, Jang H, Ahn SM, Seong JE, Kim YK, Sohn Y, Jung SI, Jeong HW, Kim SW, Lee JS, Baek JH, Lee SJ, Kwon GY, Shin J, Jeong H, Kim C, Choi JY. Lee JA, et al. Among authors: jung si. Int J Infect Dis. 2024 Nov;148:107249. doi: 10.1016/j.ijid.2024.107249. Epub 2024 Sep 20. Int J Infect Dis. 2024. PMID: 39307179 Free article.
Severe Fever with Thrombocytopenia Syndrome in South Korea, 2016-2021: Clinical Features of Severe Progression and Complications.
Lee M, Lee E, Kim SW, Kim YK, Bae IG, Kim J, Lee SS, Lee HJ, Lee CS, Jun JB, Kim HA, Jeon MH, Kim YS, Song EH, Jung SI, Baik SH, Kim DM, Kim N, Bang J, Park SW. Lee M, et al. Among authors: jung si. Am J Trop Med Hyg. 2024 Jul 9;111(3):661-670. doi: 10.4269/ajtmh.24-0062. Print 2024 Sep 4. Am J Trop Med Hyg. 2024. PMID: 38981464
Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Li R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Li R, et al. Among authors: jung si. Nat Med. 2024 Aug;30(8):2377. doi: 10.1038/s41591-024-03157-6. Nat Med. 2024. PMID: 38956199 No abstract available.
Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.
Li R, Shah PH, Stewart TF, Nam JK, Bivalacqua TJ, Lamm DL, Uchio EM, Geynisman DM, Jacob JM, Meeks JJ, Dickstein R, Pearce SM, Kang SH, Jung SI, Kamat AM, Burke JM, Keegan KA, Steinberg GD. Li R, et al. Among authors: jung si. Nat Med. 2024 Aug;30(8):2372. doi: 10.1038/s41591-024-03137-w. Nat Med. 2024. PMID: 38890533 No abstract available.
451 results